2021 Q2 Form 10-Q Financial Statement

#000164033421001346 Filed on June 14, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2 2020 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $5.110K $10.00K $0.00
YoY Change -48.9% -100.0%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $5.105K $5.238K $4.635K
YoY Change -2.54% 15.4% -19.08%
Operating Profit -$5.105K -$5.238K -$4.635K
YoY Change -2.54% 15.4% -19.08%
Interest Expense $1.448K $1.217K $1.197K
YoY Change 18.98%
% of Operating Profit
Other Income/Expense, Net -$1.448K -$1.217K -$1.197K
YoY Change 18.98% 33.59% 42.5%
Pretax Income -$6.553K -$6.455K -$5.832K
YoY Change 1.52% 18.44% -11.21%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$6.553K -$6.455K -$5.832K
YoY Change 1.52% 18.44% -11.21%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$364.10 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 39.21M shares 17.99M shares 17.99M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q2 2020 Q2 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $160.00 $0.00 $0.00
YoY Change
Cash & Equivalents $162.00 $3.174K $4.155K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $162.00 $3.174K $4.155K
YoY Change -94.9%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 -$3.174K $0.00
YoY Change -100.0%
TOTAL ASSETS
Total Short-Term Assets $162.00 $3.174K $4.155K
Total Long-Term Assets $0.00 -$3.174K $0.00
Total Assets $162.00 $0.00 $4.155K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.79K $10.00K $10.00K
YoY Change 7.87% 0.0%
Accrued Expenses $15.35K $10.00K $10.00K
YoY Change 53.5% 0.0%
Deferred Revenue
YoY Change
Short-Term Debt $120.0K $100.0K $100.0K
YoY Change 19.95% 25.0% 42.86%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $146.1K $120.0K $112.6K
YoY Change 21.74% 33.33% 40.73%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $146.1K $120.0K $112.6K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $146.1K $120.0K $112.6K
YoY Change 21.74% 33.33% 40.73%
SHAREHOLDERS EQUITY
Retained Earnings -$293.5K -$256.0K
YoY Change
Common Stock $201.4K $147.5K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$145.9K -$114.9K -$108.4K
YoY Change
Total Liabilities & Shareholders Equity $162.00 $0.00 $4.155K
YoY Change

Cashflow Statement

Concept 2021 Q2 2020 Q2 2020 Q1
OPERATING ACTIVITIES
Net Income -$6.553K -$6.455K -$5.832K
YoY Change 1.52% 18.44% -11.21%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$16.22K -$10.00K $0.00
YoY Change 62.2% 0.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 14.15K 0.000 10.00K
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -16.22K -10.00K 0.000
Cash From Investing Activities
Cash From Financing Activities 14.15K 0.000 10.00K
Net Change In Cash -2.070K -10.00K 10.00K
YoY Change -79.3% -200.0%
FREE CASH FLOW
Cash From Operating Activities -$16.22K -$10.00K $0.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
39210000 shares
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
10787 USD
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
6482 USD
CY2021Q2 us-gaap Interest Payable Current
InterestPayableCurrent
15345 USD
CY2021Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
119951 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
146083 USD
CY2021Q2 us-gaap Liabilities
Liabilities
146083 USD
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17990000 shares
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
1799 USD
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
145750 USD
CY2020Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
145750 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-293470 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-145921 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
162 USD
CY2021Q2 us-gaap Professional Fees
ProfessionalFees
4753 USD
CY2020Q2 us-gaap Professional Fees
ProfessionalFees
4307 USD
us-gaap Professional Fees
ProfessionalFees
19588 USD
us-gaap Professional Fees
ProfessionalFees
19960 USD
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
352 USD
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
931 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
937 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1444 USD
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
5105 USD
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
5238 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
162 USD
CY2021Q2 us-gaap Assets
Assets
162 USD
us-gaap Operating Expenses
OperatingExpenses
20525 USD
us-gaap Operating Expenses
OperatingExpenses
21404 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-5105 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-5238 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-121095 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-12132 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-133227 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-6141 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-20525 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-21404 USD
CY2021Q2 us-gaap Interest Expense
InterestExpense
1448 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
1217 USD
us-gaap Interest Expense
InterestExpense
4301 USD
us-gaap Interest Expense
InterestExpense
3511 USD
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1448 USD
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1217 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4301 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3511 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-6553 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-6455 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-24826 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-24915 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-6553 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-6455 USD
us-gaap Net Income Loss
NetIncomeLoss
-24826 USD
CY2021Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2021Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
17990000 shares
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
17990000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
17990000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
17990000 shares
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-139368 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-6553 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-145921 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
-89971 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-102599 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-5832 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-108431 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-114886 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4305 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
4301 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
3511 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16220 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18797 USD
us-gaap Net Income Loss
NetIncomeLoss
-24826 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
14150 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
21300 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
14150 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
21300 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2070 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2503 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2232 USD
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
671 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
162 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3174 USD
us-gaap Interest Paid
InterestPaid
0 USD
us-gaap Interest Paid
InterestPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
pnht Changes In Control Of Registrantpolicytextblock
ChangesInControlOfRegistrantpolicytextblock
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">On April 26, 2021, the board of director of the Company approved a security purchase agreement with T. Benjamin Jennings or assignees to sell and issue 21,220,000 shares of the common stock at $201,335 in cash. The issuance of 21,220,000 shares of common stock to T. Benjamin Jennings pursuant to the security purchase agreement representing around 54% of the then issued and outstanding shares of the Company at closing date. The Company received the consideration in full and issued the shares on May 12, 2021.</p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. The estimates and judgments will also affect the reported amounts for certain expenses during the reporting period. Actual results could differ from these good faith estimates and judgments.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">A novel strain of coronavirus (COVID-19) was first identified in December 2019, and subsequently declared a global pandemic by the World Health Organization on March 11, 2020. As a result of the outbreak, many companies have experienced disruptions in their operations and in markets served. The Company considered the impact of COVID-19 on the assumptions and estimates used and determined that there were no material adverse impacts on the Company’s results of operations and financial position at April 30, 2021. The full extent of the future impacts of COVID-19 on the Company’s operations is uncertain. A prolonged outbreak could have a material adverse impact on financial results and business operations of the Company, including the timing and ability of the Company to develop its business plan.</p>
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
14150 USD
CY2021Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
119951 USD
us-gaap Interest Expense
InterestExpense
4301 USD
us-gaap Interest Expense
InterestExpense
3511 USD

Files In Submission

Name View Source Status
0001640334-21-001346-index-headers.html Edgar Link pending
0001640334-21-001346-index.html Edgar Link pending
0001640334-21-001346.txt Edgar Link pending
0001640334-21-001346-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pnht-20210430.xsd Edgar Link pending
pnht-20210430_cal.xml Edgar Link unprocessable
pnht-20210430_def.xml Edgar Link unprocessable
pnht-20210430_lab.xml Edgar Link unprocessable
pnht-20210430_pre.xml Edgar Link unprocessable
pnht_10q.htm Edgar Link pending
pnht_10q_htm.xml Edgar Link completed
pnht_ex311.htm Edgar Link pending
pnht_ex312.htm Edgar Link pending
pnht_ex321.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending